Several effective SARS-CoV-2 vaccines are currently in use, but effective boosters are needed
to maintain or increase immunity due to waning responses and the emergence of novel …

Immune-mediated inflammatory diseases (IMIDs) of the joints, gut and skin are treated with
inhibitors of inflammatory cytokines. These cytokines are involved in the pathogenesis of …

RNA vaccines are efficient preventive measures to combat the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) pandemic. High levels of neutralizing SARS-CoV-2 …

The Oxford-AstraZeneca COVID-19 vaccine ChAdOx1 nCoV-19 is associated with a risk for
vaccineinduced immune thrombosis with thrombocytopenia syndrome in the range of one to …

Measles virus (MeV) is an aerosol-borne and one of the most contagious pathogenic viruses
known. Almost every MeV infection becomes clinically manifest and can lead to serious and …

Severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) infects cells
through interaction of its spike protein (SARS2-S) with angiotensin-converting enzyme 2 (ACE2) …

Background Pulmonary function measurements are important when studying respiratory
disease models. Both resistance and compliance have been used to assess lung function in …

The ability of vaccines to induce T cell responses is crucial for preventing diseases caused
by viruses or bacteria. Nanoparticles (NPs) are considered an efficient tool for inducing …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a worldwide health threat.
In a prospective multicentric study, we identify IL-3 as an independent prognostic marker …

Exosomes have been proposed as candidates for therapeutic immunization. The present
study demonstrates that incorporation of the G protein of vesicular stomatitis virus (VSV-G) into …